Lymphatic nodular staging and survival in patients operated due to non-small cell lung cancer

Introduction: In the patients with lung cancer it is vital the surgical treatment, because it facilitates a meticulous pathological staging, as well as a prognosis and treatment according to each patient tumoral charge. Objective: To determine the influence of the mediastinal limphadenectomy type i...

Full description

Bibliographic Details
Main Authors: Ana María Nazario Dolz, Gilberto Carlos Falcón Vilariño, Dunia Álvarez Matos, Zenén Rodríguez Fernández, Lázaro Ibrahim Romero García
Format: Article
Language:Spanish
Published: Centro Provincial de Información de Ciencias Médicas 2021-10-01
Series:Medisan
Subjects:
Online Access:http://www.medisan.sld.cu/index.php/san/article/view/3838
_version_ 1819364533937897472
author Ana María Nazario Dolz
Gilberto Carlos Falcón Vilariño
Dunia Álvarez Matos
Zenén Rodríguez Fernández
Lázaro Ibrahim Romero García
author_facet Ana María Nazario Dolz
Gilberto Carlos Falcón Vilariño
Dunia Álvarez Matos
Zenén Rodríguez Fernández
Lázaro Ibrahim Romero García
author_sort Ana María Nazario Dolz
collection DOAJ
description Introduction: In the patients with lung cancer it is vital the surgical treatment, because it facilitates a meticulous pathological staging, as well as a prognosis and treatment according to each patient tumoral charge. Objective: To determine the influence of the mediastinal limphadenectomy type in the survival of patients operated due to non-small cells lung cancer. Methods: A descriptive and longitudinal study was carried out in the General Surgery Service of Saturnino Lora Teaching Clinical-Surgical Provincial Hospital in Santiago de Cuba, during 10 years (from 2009 to 2019), in 55 patients selected at random who received some type of mediastinum lymphadenectomy besides lung resection. In the statistical processing, the absolute number, percentage and the mean were used, as summary measures; also the chi-squared test to identify the possible association among variables, and the Kaplan-Meier method, to specify survival. Results: The most used medistinic lymphadenectomy technique was the ganglionar sampling (47.3 %), with which a higher percentage of negative results was also obtained (84.6) as regards neoplastic invasion, contrary to that is observed with the systematic ganglionar dissection that  revealed metastasis positivity in a high number of the patients that received it (52.9 %). Likewise, patients operated by means of systematic ganglionar dissection showed a better survival 6 months later (100 %) and a year later (87.5 %); after 5 years the survival number with this technique was superior to all the types of ganglionar excisions practiced. Conclusions: There was a higher probability of the mediastinic lymphatic infiltration diagnosis and better survival in the patients treated with systematic ganglionar dissection. Reason why, it is recommended to protocolize this surgical treatment, which could be endorsed by a clinical trial that allows to compare homogeneous groups that receive each type of lymphadenectomy, respectively, in order to obtain an outstanding and conclusive scientific evidence.
first_indexed 2024-12-24T23:00:28Z
format Article
id doaj.art-73c21be480b94bf19852f78e328a019d
institution Directory Open Access Journal
issn 1029-3019
language Spanish
last_indexed 2024-12-24T23:00:28Z
publishDate 2021-10-01
publisher Centro Provincial de Información de Ciencias Médicas
record_format Article
series Medisan
spelling doaj.art-73c21be480b94bf19852f78e328a019d2022-12-21T16:35:08ZspaCentro Provincial de Información de Ciencias MédicasMedisan1029-30192021-10-012551098Lymphatic nodular staging and survival in patients operated due to non-small cell lung cancerAna María Nazario Dolz0Gilberto Carlos Falcón Vilariño1Dunia Álvarez Matos2Zenén Rodríguez Fernández3Lázaro Ibrahim Romero García4Hospital Provincial Clínico-Quirúrgico Docente Saturnino Lora. Santiago de CubaHospital Provincial Clínico-Quirúrgico Docente Saturnino Lora. Santiago de CubaHospital Provincial Clínico-Quirúrgico Docente Saturnino Lora. Santiago de CubaHospital Provincial Clínico-Quirúrgico Docente Saturnino Lora. Santiago de CubaHospital Provincial Clínico-Quirúrgico Docente Saturnino Lora. Santiago de CubaIntroduction: In the patients with lung cancer it is vital the surgical treatment, because it facilitates a meticulous pathological staging, as well as a prognosis and treatment according to each patient tumoral charge. Objective: To determine the influence of the mediastinal limphadenectomy type in the survival of patients operated due to non-small cells lung cancer. Methods: A descriptive and longitudinal study was carried out in the General Surgery Service of Saturnino Lora Teaching Clinical-Surgical Provincial Hospital in Santiago de Cuba, during 10 years (from 2009 to 2019), in 55 patients selected at random who received some type of mediastinum lymphadenectomy besides lung resection. In the statistical processing, the absolute number, percentage and the mean were used, as summary measures; also the chi-squared test to identify the possible association among variables, and the Kaplan-Meier method, to specify survival. Results: The most used medistinic lymphadenectomy technique was the ganglionar sampling (47.3 %), with which a higher percentage of negative results was also obtained (84.6) as regards neoplastic invasion, contrary to that is observed with the systematic ganglionar dissection that  revealed metastasis positivity in a high number of the patients that received it (52.9 %). Likewise, patients operated by means of systematic ganglionar dissection showed a better survival 6 months later (100 %) and a year later (87.5 %); after 5 years the survival number with this technique was superior to all the types of ganglionar excisions practiced. Conclusions: There was a higher probability of the mediastinic lymphatic infiltration diagnosis and better survival in the patients treated with systematic ganglionar dissection. Reason why, it is recommended to protocolize this surgical treatment, which could be endorsed by a clinical trial that allows to compare homogeneous groups that receive each type of lymphadenectomy, respectively, in order to obtain an outstanding and conclusive scientific evidence.http://www.medisan.sld.cu/index.php/san/article/view/3838carcinoma de pulmón de células no pequeñasestadificación de neoplasiasresección pulmonarescisión del ganglio linfáticosupervivencia.
spellingShingle Ana María Nazario Dolz
Gilberto Carlos Falcón Vilariño
Dunia Álvarez Matos
Zenén Rodríguez Fernández
Lázaro Ibrahim Romero García
Lymphatic nodular staging and survival in patients operated due to non-small cell lung cancer
Medisan
carcinoma de pulmón de células no pequeñas
estadificación de neoplasias
resección pulmonar
escisión del ganglio linfático
supervivencia.
title Lymphatic nodular staging and survival in patients operated due to non-small cell lung cancer
title_full Lymphatic nodular staging and survival in patients operated due to non-small cell lung cancer
title_fullStr Lymphatic nodular staging and survival in patients operated due to non-small cell lung cancer
title_full_unstemmed Lymphatic nodular staging and survival in patients operated due to non-small cell lung cancer
title_short Lymphatic nodular staging and survival in patients operated due to non-small cell lung cancer
title_sort lymphatic nodular staging and survival in patients operated due to non small cell lung cancer
topic carcinoma de pulmón de células no pequeñas
estadificación de neoplasias
resección pulmonar
escisión del ganglio linfático
supervivencia.
url http://www.medisan.sld.cu/index.php/san/article/view/3838
work_keys_str_mv AT anamarianazariodolz lymphaticnodularstagingandsurvivalinpatientsoperatedduetononsmallcelllungcancer
AT gilbertocarlosfalconvilarino lymphaticnodularstagingandsurvivalinpatientsoperatedduetononsmallcelllungcancer
AT duniaalvarezmatos lymphaticnodularstagingandsurvivalinpatientsoperatedduetononsmallcelllungcancer
AT zenenrodriguezfernandez lymphaticnodularstagingandsurvivalinpatientsoperatedduetononsmallcelllungcancer
AT lazaroibrahimromerogarcia lymphaticnodularstagingandsurvivalinpatientsoperatedduetononsmallcelllungcancer